Increased serum levels of endogenous protectant secretory leukocyte protease inhibitor in acute ischemic stroke patients

Cerebrovascular Diseases

Volumn 13, Issue 1, 2002, Pages 38-42

  Iłzecka, Joanna ^a   Stelmasiak, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Ischemic stroke; Leukocytes; Secretory leukocyte protease inhibitor

Indexed keywords

SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUROPROTECTION; PRIORITY JOURNAL; PROTEINASE INHIBITION;

ACUTE DISEASE; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 0036159628     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047744     Document Type: Article

References (21)

1. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA
2. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases
3. Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin
4. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis
5. The serine-protease inhibitor of cartilage matrix is not a chondrocytic gene product
6. Advantages and disadvantages of neurological scales
7. The stroke data bank: Design, methods and baseline characteristics
8. The action of prostaglandin E2 on the human cervix: Stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor
9. Tissue destruction by neutrophils
10. Acute phase response in cerebral infarction
11. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke
12. Imaging of leukocytic infiltration in human cerebral infarcts
13. Leukocyte infiltration in acute hemispheric ischemic stroke
14. Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation
15. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase
16. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage
17. Secretory leukocyte protease inhibitor is a major leukocyte elastase inhibitor in human neutrophils
18. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor
19. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases
20. Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection
21. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion